Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Ribotyping of Clostridium difficile strains associated with nosocomial transmission and relapses in a Swedish County.

Magnusson C, Wullt M, Löfgren S, Iveroth P, Akerlund T, Matussek A.

APMIS. 2013 Feb;121(2):153-7. doi: 10.1111/j.1600-0463.2012.02950.x. Epub 2012 Jul 25.

2.

[Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].

Poilane I, Fantinato C, Cruaud P, Collignon A.

Pathol Biol (Paris). 2008 Nov-Dec;56(7-8):412-6. doi: 10.1016/j.patbio.2008.07.009. Epub 2008 Oct 7. French.

PMID:
18842360
3.

Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.

Spigaglia P, Barbanti F, Dionisi AM, Mastrantonio P.

J Clin Microbiol. 2010 Aug;48(8):2892-6. doi: 10.1128/JCM.02482-09. Epub 2010 Jun 16.

4.

Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors.

Sundram F, Guyot A, Carboo I, Green S, Lilaonitkul M, Scourfield A.

J Hosp Infect. 2009 Jun;72(2):111-8. doi: 10.1016/j.jhin.2009.02.020. Epub 2009 Apr 21.

PMID:
19386381
5.

Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR-ribotypes 012, 017 and 046 in Sweden, 2008 and 2009.

Akerlund T, Alefjord I, Dohnhammar U, Struwe J, Noren T, Tegmark-Wisell K; Swedish C. difficile Study Group.

Euro Surveill. 2011 Mar 10;16(10). pii: 19813.

6.

The epidemiology of Clostridium difficile in Scotland.

Wiuff C, Brown DJ, Mather H, Banks AL, Eastaway A, Coia JE.

J Infect. 2011 Apr;62(4):271-9. doi: 10.1016/j.jinf.2011.01.015. Epub 2011 Feb 22.

PMID:
21300104
7.

PCR ribotyping and arbitrarily primed PCR for typing strains of Clostridium difficile from a Polish maternity hospital.

Martirosian G, Kuipers S, Verbrugh H, van Belkum A, Meisel-Mikolajczyk F.

J Clin Microbiol. 1995 Aug;33(8):2016-21.

8.

Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008.

Ilchmann C, Zaiss NH, Speicher A, Christner M, Ackermann G, Rohde H.

Eur J Clin Microbiol Infect Dis. 2010 Dec;29(12):1571-3. doi: 10.1007/s10096-010-1017-9. Epub 2010 Jul 15.

PMID:
20632051
9.

Clostridium difficile ribotype 027, toxinotype III, the Netherlands.

Kuijper EJ, van den Berg RJ, Debast S, Visser CE, Veenendaal D, Troelstra A, van der Kooi T, van den Hof S, Notermans DW.

Emerg Infect Dis. 2006 May;12(5):827-30.

10.

Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.

Huang H, Wu S, Wang M, Zhang Y, Fang H, Palmgren AC, Weintraub A, Nord CE.

Int J Antimicrob Agents. 2009 Apr;33(4):339-42. doi: 10.1016/j.ijantimicag.2008.09.022. Epub 2008 Dec 20.

PMID:
19097757
11.

PCR ribotyping of clinically important Clostridium difficile strains from Hungary.

Urbán E, Brazier JS, Sóki J, Nagy E, Duerden BI.

J Med Microbiol. 2001 Dec;50(12):1082-6.

PMID:
11761193
12.

Clostridium difficile infection in an Iranian hospital.

Jalali M, Khorvash F, Warriner K, Weese JS.

BMC Res Notes. 2012 Mar 21;5:159. doi: 10.1186/1756-0500-5-159.

13.

Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county.

Norén T, Akerlund T, Bäck E, Sjöberg L, Persson I, Alriksson I, Burman LG.

J Clin Microbiol. 2004 Aug;42(8):3635-43.

14.

Changes in antibiotic susceptibility and ribotypes in Clostridium difficile isolates from southern Scotland, 1979-2004.

Taori SK, Hall V, Poxton IR.

J Med Microbiol. 2010 Mar;59(Pt 3):338-44. doi: 10.1099/jmm.0.014829-0. Epub 2009 Nov 26.

PMID:
19942691
15.

Molecular analysis of Clostridium difficile at a university teaching hospital in Japan: a shift in the predominant type over a five-year period.

Sawabe E, Kato H, Osawa K, Chida T, Tojo N, Arakawa Y, Okamura N.

Eur J Clin Microbiol Infect Dis. 2007 Oct;26(10):695-703.

PMID:
17647032
16.

Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany.

Arvand M, Hauri AM, Zaiss NH, Witte W, Bettge-Weller G.

Euro Surveill. 2009 Nov 12;14(45). pii: 19403.

17.

Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil.

Balassiano IT, dos Santos-Filho J, Vital-Brazil JM, Nouér SA, Souza CR, Brazier JS, Ferreira Ede O, Domingues RM.

Antonie Van Leeuwenhoek. 2011 Feb;99(2):249-55. doi: 10.1007/s10482-010-9483-8. Epub 2010 Jul 11.

PMID:
20623188
18.

Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006-2007.

Fenner L, Frei R, Gregory M, Dangel M, Stranden A, Widmer AF.

Eur J Clin Microbiol Infect Dis. 2008 Dec;27(12):1201-7. doi: 10.1007/s10096-008-0564-9. Epub 2008 Jun 17.

PMID:
18560909
19.

Epidemiological survey of Clostridium difficile ribotypes in the North East of England during an 18-month period.

Vanek J, Hill K, Collins J, Berrington A, Perry J, Inns T, Gorton R, Magee J, Sails A, Mullan A, Gould FK.

J Hosp Infect. 2012 Jul;81(3):209-12. doi: 10.1016/j.jhin.2012.04.017. Epub 2012 May 24.

PMID:
22633277
20.

Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007.

Cheknis AK, Sambol SP, Davidson DM, Nagaro KJ, Mancini MC, Hidalgo-Arroyo GA, Brazier JS, Johnson S, Gerding DN.

Anaerobe. 2009 Dec;15(6):230-3. doi: 10.1016/j.anaerobe.2009.09.001. Epub 2009 Sep 6.

PMID:
19737618
Items per page

Supplemental Content

Write to the Help Desk